Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia

被引:55
作者
Boselli, E [1 ]
Breilh, D
Rimmelé, T
Djabarouti, S
Saux, MC
Chassard, D
Allaouchiche, B
机构
[1] Hop Hotel Dieu, Dept Anesthesiol & Intens Care, F-69288 Lyon, France
[2] Univ Bordeaux 2, Haut Leveque Hosp, Clin Pharmacokinet Lab, F-33076 Bordeaux, France
[3] Hop Edouard Herriot, Dept Anesthesiol & Intens Care, Lyon, France
关键词
levofloxacin; pharmacokinetics; lung diffusion; community-acquired pneumonia; intensive care;
D O I
10.1097/01.CCM.0000150265.42067.4C
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine the steady-state plasma and epithelial lining fluid concentrations of intravenous levofloxacin, 500 mg, administered once or twice daily in critically ill patients with severe community-acquired pneumonia. Design: Prospective, open-label study. Setting: An intensive care unit and a clinical pharmacokinetic laboratory in two university hospitals. Patients: Twenty-four adult patients with severe communityacquired pneumonia and receiving mechanical ventilation were enrolled. Interventions: All subjects received 1-hr intravenous infusions of 500 mg levofloxacin once or twice daily. The plasma and epithelial lining fluid levofloxacin concentrations were determined at steady-state after 2 days of therapy with high-performance liquid chromallography. Measurements and main results: The median (interquartile range [IQR]) plasma and epithelial lining fluid peak levofloxacin concentrations were 12.6 (IQR, 12.0-14.1) and 11.9 (IQR, 8.7-13.7) mg/L, respectively, in the once-daily group and 19.7 (IQR, 19.0-22.0) and 17.8 (IQR, 16.2-23.5) mg/L in the twice-daily group, showing a pulmonary percentage penetration of >100% in both groups. The median (lQR) total body exposures were 151 (IQR, 137-174) and 416 (IQR, 406-472) mg-hr/L, respectively, in the once-daily and twice-daily groups. Conclusions: Our results suggest that in critically ill patients who are receiving mechanical ventilation and have severe communityacquired pneumonia and creatinine clearance of >40 mL/min, the administration of 500 mg of intravenous levofloxacin once and twice daily allows for the exceeding of pharmacodynamic thresholds predictive of outcome (i.e., peak concentration to minimum inhibitory concentration ratio of >10 or area under concentration-time curve to minimal inhibitory concentration ratio of >125 hrs) both in serum and epithelial lining fluid for pathogens with minimum inhibitory concentration values of less than or equal to1 mg/L and >1 mg/L, respectively.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 35 条
  • [1] Community-acquired pneumonia
    Andrews, J
    Nadjm, B
    Gant, V
    Shetty, N
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (03) : 175 - 180
  • [2] Pharmacological indices in antibiotic therapy
    Barger, A
    Fuhst, C
    Wiedemann, B
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) : 893 - 898
  • [3] COMMUNITY-ACQUIRED PNEUMONIA
    BARTLETT, JG
    MUNDY, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1618 - 1624
  • [4] Community-acquired pneumonia in adults: Guidelines for management
    Bartlett, JG
    Breiman, RF
    Mandell, LA
    File, TM
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 811 - 838
  • [5] New concepts in the pulmonary disposition of antibiotics
    BergogneBerezin, E
    [J]. PULMONARY PHARMACOLOGY, 1995, 8 (2-3): : 65 - 81
  • [6] Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia
    Boselli, E
    Breilh, D
    Rimmelé, T
    Poupelin, JC
    Saux, MC
    Chassard, D
    Allaouchiche, B
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (05) : 989 - 991
  • [7] Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia
    Boselli, E
    Breilh, D
    Cannesson, M
    Xuereb, F
    Rimmelé, T
    Chassard, D
    Saux, MC
    Allaouchiche, B
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (05) : 976 - 979
  • [8] Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia
    Boselli, E
    Breilh, D
    Duflo, F
    Saux, MC
    Debon, R
    Chassard, D
    Allaouchiche, B
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (08) : 2102 - 2106
  • [9] Boselli E, 2001, ANN FR ANESTH, V20, P612
  • [10] In vitro antibacterial activity and phamacodynamics of new quinolones
    Dalhoff, A
    Schmitz, FJ
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (04) : 203 - 221